Nancy Klauber
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Oncology 2
- Vascular Tumors and Angiosarcomas 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- Evelyn Flynn (4 shared papers)Robert J. D’Amato (4 shared papers)Sareh Parangi (2 shared papers)Édith Hamel (1 shared paper)Richard M. Rohan (2 shared papers)H. Randolph Byers (2 shared papers)Carolyn Fisher (1 shared paper)Jack L. Arbiser (1 shared paper)
- Journals
- Nature Medicine (1 paper)Molecular Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Circulation (1 paper)Journal of the American Academy of Dermatology (1 paper)
- Partner nations
- United States
In The Last Decade
Nancy Klauber
6 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 83
- Molecular Medicine 176
- Cancer Research 261
- Oncology 343
- Reproductive Medicine 99
- Toxicology 38
Countries citing papers authored by Nancy Klauber
This map shows the geographic impact of Nancy Klauber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Klauber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Klauber more than expected).
Fields of papers citing papers by Nancy Klauber
This network shows the impact of papers produced by Nancy Klauber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Klauber. The network helps show where Nancy Klauber may publish in the future.
Co-authors
The 20 scholars most cited alongside Nancy Klauber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. | 1997 | 451 |
| 2 | 1997 | 411 | |
| 3 | 1998 | 337 | |
| 4 | 1997 | 161 | |
| 5 | 1996 | 56 | |
| 6 | 1999 | 38 |
About Nancy Klauber
Nancy Klauber is a scholar working on Molecular Biology, Oncology, Obstetrics and Gynecology, Molecular Medicine and Endocrinology, Diabetes and Metabolism, having authored 6 papers that have together received 1.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Protease and Inhibitor Mechanisms (1 paper), Reproductive System and Pregnancy (1 paper), Estrogen and related hormone effects (1 paper), Cancer Treatment and Pharmacology (1 paper) and Curcumin's Biomedical Applications (1 paper). The work is most often cited by research in Molecular Medicine (176 citations), Cancer Research (261 citations), Oncology (343 citations), Reproductive Medicine (99 citations) and Toxicology (38 citations). Nancy Klauber has collaborated with scholars based in United States. Frequent co-authors include Evelyn Flynn, Robert J. D’Amato, Sareh Parangi, Édith Hamel, Richard M. Rohan, H. Randolph Byers, Carolyn Fisher, Jack L. Arbiser, Mou-Tuan Huang and Jack L. Arbiser. Their work appears in journals such as Nature Medicine, Molecular Medicine, Proceedings of the National Academy of Sciences, Circulation and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.